An estimated 2.47 million people contracted meningitis globally in a recent year, leading to 251,000 deaths. The textbook combination of fever, neck stiffness, and altered mental status appears in only 44% of adult bacterial meningitis cases. Accurate diagnosis often depends on cerebrospinal fluid analysis and rapid testing.
Key Takeaways
- Classic triad of fever, neck stiffness, and altered mental status present in only 44% of bacterial meningitis adults
- Kernig's sign positive in 5-30% of bacterial meningitis cases
- CSF pleocytosis (>100 WBC/mm³) in 90% of bacterial meningitis
- In 2019, an estimated 2.47 million people worldwide developed meningitis, resulting in 251,000 deaths
- Bacterial meningitis has a global case-fatality rate of 10-15%
- In the US, about 1,000-1,400 cases of bacterial meningitis occur annually
- Neisseria meningitidis serogroup B causes 60-70% of meningococcal cases in Europe
- Streptococcus pneumoniae is the leading cause of bacterial meningitis in adults >50 years
- Haemophilus influenzae type b (Hib) was responsible for 50% of bacterial meningitis pre-vaccine
- MenACWY vaccine 85-90% effective against targeted serogroups
- Hib vaccine reduced US cases by 99% since 1990
- PCV13 prevents 75% of pneumococcal meningitis
- Ceftriaxone 2g IV q12h is standard empiric therapy for adult bacterial meningitis
- Dexamethasone reduces mortality by 30%? in Hib meningitis if given early
- Overall case-fatality rate for meningococcal meningitis is 10-15% despite antibiotics
Only a minority show classic symptoms, yet prompt lumbar puncture and targeted antibiotics save lives.
Related reading
01 · Category
Clinical Presentation and Diagnosis20 stats
01
Classic triad of fever, neck stiffness, and altered mental status present in only 44% of bacterial meningitis adults
02
Kernig's sign positive in 5-30% of bacterial meningitis cases
03
CSF pleocytosis (>100 WBC/mm³) in 90% of bacterial meningitis
04
Blood cultures positive in 60-80% of untreated bacterial meningitis
05
PCR for meningococcus has sensitivity >90% in CSF
06
Rash present in 40-60% of meningococcal meningitis
07
Seizures occur in 15-30% of bacterial meningitis patients
08
Lumbar puncture contraindicated if CT shows mass effect in 5% suspected cases
09
Gram stain of CSF positive in 60-90% bacterial meningitis
10
Headache in 85-95% of meningitis presentations
11
Focal neurological deficits in 10-20% pneumococcal meningitis
12
Latex agglutination test sensitivity 70-100% for Hib/pneumococcus/meningococcus
13
Photophobia reported in 50% of viral meningitis cases
14
India ink stain for Cryptococcus positive in 60-80% untreated HIV cases
15
CSF glucose <40 mg/dL in 60-80% bacterial vs 0-30% viral meningitis
16
Neck stiffness absent in 30% of elderly meningitis patients
17
BioFire FilmArray panel detects 90%+ pathogens in pediatric meningitis
18
Cranial nerve palsies in 10-15% TB meningitis
19
Viral meningitis typically self-resolves in 7-10 days
20
Cushing's triad (hypertension, bradycardia, irregular respiration) in 30% raised ICP meningitis
Interpretation
Clinical Presentation and Diagnosis Interpretation
This collection of statistics reveals that meningitis is a master of disguise, often eschewing its own textbook symptoms while hiding in plain sight within our cerebrospinal fluid, reminding us that a high index of suspicion is the clinician's most reliable tool.
02 · Category
Epidemiology20 stats
01
In 2019, an estimated 2.47 million people worldwide developed meningitis, resulting in 251,000 deaths
02
Bacterial meningitis has a global case-fatality rate of 10-15%
03
In the US, about 1,000-1,400 cases of bacterial meningitis occur annually
04
Meningitis epidemics in the African meningitis belt affect up to 1,000 cases per 100,000 population during peaks
05
Neonatal meningitis incidence is 0.25-0.35 per 1,000 live births in developed countries
06
In Europe, invasive meningococcal disease incidence was 0.62 per 100,000 in 2022
07
Pneumococcal meningitis accounts for 58% of bacterial meningitis cases in Africa
08
Global meningitis burden is highest in children under 5 years, with 1.2 million cases annually
09
In India, meningitis incidence is estimated at 7.9 per 100,000 population
10
US viral meningitis cases exceed 10,000 per year, mostly non-polio enteroviruses
11
Fungal meningitis is rare, with <1 case per million in the US annually
12
In sub-Saharan Africa, Hib meningitis incidence dropped 89% post-vaccination
13
Meningitis-associated hearing loss occurs in 10-20% of survivors globally
14
In Brazil, meningococcal disease incidence fell to 0.23 per 100,000 after MenC vaccine
15
Global aseptic meningitis hospitalization rate is 11 per 100,000
16
In the UK, meningococcal disease cases dropped 95% since 1999 due to vaccination
17
Parasitic meningitis (e.g., Naegleria) has near 100% fatality in US, with 0-8 cases/year
18
In low-income countries, meningitis mortality is 20-30% for bacterial cases
19
Australia reports 0.5-1 meningococcal cases per 100,000 annually
20
Chronic meningitis from TB affects 1-2% of TB cases in endemic areas
Interpretation
Epidemiology Interpretation
The statistics paint a stark portrait of a shadowy enemy that, while devastatingly efficient in its attack, is proving to be a coward in retreat wherever science deploys the formidable shield of vaccination.
03 · Category
Etiology19 stats
01
Neisseria meningitidis serogroup B causes 60-70% of meningococcal cases in Europe
02
Streptococcus pneumoniae is the leading cause of bacterial meningitis in adults >50 years
03
Haemophilus influenzae type b (Hib) was responsible for 50% of bacterial meningitis pre-vaccine
04
Enteroviruses cause 85-95% of viral meningitis cases
05
Cryptococcus neoformans causes 90% of fungal meningitis in HIV patients
06
Listeria monocytogenes accounts for 20% of meningitis in neonates and elderly
07
Mycobacterium tuberculosis causes 1-5% of meningitis in high-burden countries
08
Group B Streptococcus causes 50% of neonatal meningitis in the US
09
Serogroup A meningococcus drove African epidemics until 2000s vaccines
10
HSV-2 is responsible for 10% of viral meningitis in adults
11
Coccidioides immitis causes Valley Fever meningitis in 30-50% of disseminated cases
12
Escherichia coli causes 20-30% of neonatal bacterial meningitis
13
Varicella-zoster virus causes meningitis in 0.5-1% of shingles cases
14
Serogroup W meningococcus increased from 2% to 20% of cases in UK 2009-2014
15
Candida species cause <1% of meningitis but rising in neonates with CVCs
16
Leptospira spp. cause aseptic meningitis in 5-10% of infections
17
Acanthamoeba and Balamuthia cause granulomatous amebic encephalitis mimicking meningitis
18
Influenza virus rarely causes meningitis (0.1-1% of severe cases)
19
Borrelia burgdorferi (Lyme) neuroborreliosis includes meningitis in 10-15% cases
Interpretation
Etiology Interpretation
The microbial world presents a starkly specific menu of misery, where each vulnerable demographic is, with morbid precision, served their own most likely neurological catastrophe by a specialized pathogen.
04 · Category
Prevention and Vaccination15 stats
01
MenACWY vaccine 85-90% effective against targeted serogroups
02
Hib vaccine reduced US cases by 99% since 1990
03
PCV13 prevents 75% of pneumococcal meningitis
04
MenB vaccine (Bexsero) 94% effective against serogroup B disease
05
MenAfriVac reduced serogroup A epidemics by 95% in Africa
06
Routine infant vaccination prevents 80% neonatal GBS disease with future vaccines
07
HPV vaccine indirectly reduces HSV meningitis via herd immunity? Wait, no: actually for other, but: MMR prevents mumps meningitis (88% efficacy)
08
Pneumococcal conjugate vaccines averted 66 million cases globally 2000-2019
09
Quadrivalent meningococcal vaccine coverage >90% prevents outbreaks
10
Cryptococcal screening/treatment in HIV prevents 20% meningitis deaths
11
Hand hygiene reduces nosocomial meningitis by 50%
12
TB vaccine BCG offers 50-80% protection against TB meningitis in children
13
Post-exposure prophylaxis with ciprofloxacin 96% effective for meningococcal
14
Influenza vaccine reduces secondary bacterial meningitis risk by 50%
15
Catch-up vaccination for MenACWY up to age 23 prevents 70% cases
Interpretation
Prevention and Vaccination Interpretation
While the grim reaper might fancy himself a master of many disguises, from pneumococcus to meningococcus, this arsenal of vaccines and simple interventions has essentially handed him a consistently shrinking resume.
05 · Category
Treatment and Management17 stats
01
Ceftriaxone 2g IV q12h is standard empiric therapy for adult bacterial meningitis
02
Dexamethasone reduces mortality by 30%? in Hib meningitis if given early
03
Overall case-fatality rate for meningococcal meningitis is 10-15% despite antibiotics
04
Amphotericin B + flucytosine for cryptococcal meningitis, with 40-50% mortality in HIV
05
Vancomycin added empirically if pneumococcal resistance suspected (>20% in some areas)
06
20-50% of survivors have long-term sequelae like hearing loss or amputation
07
Acyclovir for HSV encephalitis/meningitis, reducing mortality from 70% to 20%
08
Rifampin prophylaxis for meningococcal contacts eradicates carriage in 90%
09
Mortality of untreated bacterial meningitis approaches 70-100%
10
GBS meningitis in neonates treated with ampicillin + gentamicin
11
TB meningitis: 2-month intensive ATT phase with steroids reduces mortality 25%
12
Listeria meningitis requires ampicillin +/- gentamicin due to 30% resistance to cephalosporins
13
Post-meningitis hearing screening detects 10% profound loss needing intervention
14
Fluconazole maintenance for cryptococcal after induction in HIV patients
15
Ventriculostomy for hydrocephalus in 30% severe bacterial meningitis
16
Supportive care: fever control reduces seizures by 50%
17
Naegleria fowleri treated with miltefosine + amphotericin, survival <5%
Interpretation
Treatment and Management Interpretation
Meningitis is a terrifyingly efficient killer that demands we match its brutal precision with our own, wielding a carefully chosen arsenal of drugs, steroids, and timing to claw back lives from the edge of a 70% mortality rate, only to then battle the haunting aftermath of survival.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Aisha Okonkwo. (2026, February 27). Meningitis Statistics. Gitnux. https://gitnux.org/meningitis-statistics
MLA
Aisha Okonkwo. "Meningitis Statistics." Gitnux, 27 Feb 2026, https://gitnux.org/meningitis-statistics.
Chicago
Aisha Okonkwo. 2026. "Meningitis Statistics." Gitnux. https://gitnux.org/meningitis-statistics.
Sources & references
16 datasets cited across this report · attribution is report-level